InvestSMART

Cochlear Limited (ASX: COH) - Announcements

- Current share price for COH : $129.500

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8,469 Cochlear agrees to acquire Oticon Medical 27 Apr 2022 4:06PM $230.750 $129.500 fallen by 43.88%
$8,469 Notification of cessation of securities - COH 12 Apr 2022 2:57PM $223.370 $129.500 fallen by 42.02%
$8,469 Change in substantial holding 7 Apr 2022 8:22AM $225.150 $129.500 fallen by 42.48%
$8,469 Notification of cessation of securities - COH 29 Mar 2022 3:17PM $218.730 $129.500 fallen by 40.79%
$8,469 Half Year Results Presentation 22 Feb 2022 8:26AM $190.250 $129.500 fallen by 31.93%
$8,469 Half Year Results Announcement 22 Feb 2022 8:24AM $190.250 $129.500 fallen by 31.93%
$8,469 Dividend/Distribution - COH 22 Feb 2022 8:23AM $190.250 $129.500 fallen by 31.93%
$8,469 Appendix 4D and Half Year Financial Report 22 Feb 2022 8:23AM $190.250 $129.500 fallen by 31.93%
$8,469 Application for quotation of securities - COH 1 Feb 2022 10:37AM $194.190 $129.500 fallen by 33.31%
$8,469 Notification of cessation of securities - COH 13 Jan 2022 12:38PM $206.040 $129.500 fallen by 37.15%
$8,469 Notice of HY22 result analyst and media briefing 11 Jan 2022 2:31PM $206.080 $129.500 fallen by 37.16%
$8,469 Appendix 3X - Michael del Prado 5 Jan 2022 9:57AM $222.740 $129.500 fallen by 41.86%
$8,469 Appointment of Michael del Prado to Cochlear Board 17 Dec 2021 5:03PM $207.620 $129.500 fallen by 37.63%
$8,469 Change in leadership for Cochlear North America 8 Dec 2021 9:40AM $214.720 $129.500 fallen by 39.69%
$8,469 Becoming a substantial holder 15 Nov 2021 8:35AM $219.570 $129.500 fallen by 41.02%
$8,469 Jobkeeper Payments Notification 11 Nov 2021 3:25PM $219.910 $129.500 fallen by 41.11%
$8,469 Ceasing to be a substantial holder 3 Nov 2021 8:15AM $226.300 $129.500 fallen by 42.78%
$8,469 Appendix 3Y - Christine Frances McLoughlin 29 Oct 2021 3:32PM $220.640 $129.500 fallen by 41.31%
$8,469 Notification regarding unquoted securities - COH 29 Oct 2021 11:00AM $224.685 $129.500 fallen by 42.36%
$8,469 Notification regarding unquoted securities - COH 26 Oct 2021 3:15PM $223.530 $129.500 fallen by 42.07%
$8,469 Appendix 3Y - Diggory Howitt 22 Oct 2021 11:04AM $225.580 $129.500 fallen by 42.59%
$8,469 Becoming a substantial holder 22 Oct 2021 8:18AM $219.960 $129.500 fallen by 41.13%
$8,469 Notification regarding unquoted securities - COH 21 Oct 2021 2:08PM $221.610 $129.500 fallen by 41.56%
$8,469 Results of Meeting 19 Oct 2021 2:49PM $221.890 $129.500 fallen by 41.64%
$8,469 2021 AGM - Chair and CEO & President's address 19 Oct 2021 9:33AM $215.240 $129.500 fallen by 39.83%

451 - 475 of 941 results

Page 19 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.